Biotech Files EU Application for Precision-Fermented Milk Protein
Danish start-up 21st.Bio seeks European approval for a dairy protein made without animal input.
Updated on Nov. 18, 2026 in Organic Food

Live Poll
Should the EU fast-track approval of lab-made milk proteins like this one?
21st.Bio, a Danish biotech start-up, has filed an EU Novel Food application for its precision-fermented bovine beta-lactoglobulin (BLG). The milk protein is produced without animal input and received US regulatory approval for sales in October 2025.
Why it matters
If approved, the product would support resource-efficient dairy protein production in Europe amid ongoing supply constraints affecting the whey protein market. BLG is the predominant protein in milk-derived whey, making it a central ingredient for the category.
The filing is a regulatory application for a novel food ingredient, with US sales approval already secured in October 2025. The EU decision timeline has not been stated, and no approval date has been set.
The players
21st.Bio
21st.Bio is a Danish biotech start-up developing precision-fermented dairy proteins produced without animal input.
Novonesis
Novonesis is a biosolutions company that developed and refined the Aspergillus oryzae production platform later licensed by 21st.Bio.
The details
BLG Essential+ is produced using Aspergillus oryzae, a microorganism used for centuries in Japanese food fermentation. Precision fermentation trains microorganisms to produce specific targeted ingredients in bioreactors, and the production platform was developed and refined by Novonesis before 21st.Bio licensed and advanced it for alt-protein production at scale.
Timeline
October 2025: US regulatory approval for sales of the BLG product was obtained.
2025: A peer-reviewed study in Applied Microbiology and Biotechnology described the strain lineage as the first mycotoxin-free A. oryzae lineage for industrial production of alternative proteins.
18 November 2026: 21st.Bio filed its EU Novel Food application.
Market Landscape
The application places precision-fermented BLG within the broader push to produce dairy proteins without livestock, extending a platform already approved for sale in the United States. It positions the company to compete in an alt-protein market where whey supply remains constrained.
If the EU approves the ingredient, European food makers could gain a new animal-free milk protein option for dairy-style products. Consumers would not see changes to shelves until approval and product launches occur.
The takeaway
Precision-fermented proteins are moving from lab development toward regulated sale, with US approval already in hand. Watch for the EU Novel Food decision to see whether animal-free dairy ingredients reach European markets.
Further reading
Explore more on Organic Food to see how alternative dairy ingredients fit into the wider natural-food landscape.
Source note: This article includes information reported by FoodBev Media.
Live Poll
Should the EU fast-track approval of lab-made milk proteins like this one?







